hydroquinone has been researched along with tretinoin in 107 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (1.87) | 18.7374 |
| 1990's | 11 (10.28) | 18.2507 |
| 2000's | 44 (41.12) | 29.6817 |
| 2010's | 46 (42.99) | 24.3611 |
| 2020's | 4 (3.74) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kalf, GF; Oliveira, NL | 1 |
| Nair, X; Tramposch, KM | 1 |
| Fitzpatrick, TB; Kraus, EW; Pathak, MA | 1 |
| Grimes, PE | 2 |
| Hedli, CC; Rao, NR; Reuhl, KR; Snyder, R; Witmer, CM | 1 |
| Burns, RL; Faria, DT; Fivenson, DP; Lawry, MA; Lawry, TB; Prevost-Blank, PL | 1 |
| Apfelberg, DB | 1 |
| Brewer, GJ; Quitschke, WW; Yang, Y | 1 |
| Chun, SC; Kang, WH; Lee, S | 1 |
| Alster, TS; West, TB | 1 |
| Eaglstein, W; Hasan, AT; Pardo, RJ | 1 |
| Kauh, YC; Zachian, TF | 1 |
| Aoyama, T; Harii, K; Iga, T; Yoshimura, K | 1 |
| Chess, C | 1 |
| Muir, J; Ozluer, SM | 1 |
| Guevara, IL; Pandya, AG | 1 |
| Harii, K; Kitano, Y; Lei, TC; Okazaki, M; Suzuki, Y; Tsukamoto, K; Uchida, G; Virador, VM; Yoshimura, K | 1 |
| Levin, CY; Maibach, H | 1 |
| Bhalla, M; Kanwar, AJ; Kaur, C; Sarkar, R | 1 |
| Aiba, E; Aoyama, T; Harii, K; Iga, T; Matsumoto, D; Momosawa, A; Sato, K; Watanabe, A; Yamamoto, T; Yoshimura, K | 1 |
| Aslani, FS; Handjani, F; Kasraee, B | 1 |
| Gupta, AK; Ryder, JE | 1 |
| Aiba, E; Aoyama, T; Harii, K; Iga, T; Matsumoto, D; Mihara, S; Momosawa, A; Sato, K; Tsukamoto, K; Uchida, G; Yamaoka, H; Yoshimura, K | 1 |
| Grover, C; Nanda, S; Reddy, BS | 1 |
| Halder, RM; Richards, GM | 1 |
| Jarratt, M | 1 |
| Cayce, KA; Feldman, SR; McMichael, AJ | 1 |
| Jones, T; Rich, P; Smith, S; Torok, HM; Tschen, E | 1 |
| Astaneh, R; Farboud, E; Nazemi, MJ | 1 |
| Draelos, ZD | 1 |
| Grimes, P; Kelly, AP; Torok, H; Willis, I | 1 |
| Aiba-Kojima, E; Gonda, K; Koshima, I; Machino, C; Matsumoto, D; Nagase, T; Sato, K; Yoshimura, K | 1 |
| Torok, HM | 1 |
| Gover, MD; Gupta, AK; Nouri, K; Taylor, S | 1 |
| Arellano, I; Hexsel, D; Rendon, M | 1 |
| Almeida, AR; Azulay, L; Cestari, TF; Filho, JW; Hassun, K; Hexsel, D; Junqueira, H; Mendes, AM; Rêgo, VR; Viegas, ML | 1 |
| de Lourdes Viegas, M; Ferreira Cestari, T; Hassun, K; Sittart, A | 1 |
| Adjadj, L; Cestari, T; Hux, M; Rives, VP; Shimizu, MR | 1 |
| Buggiani, G; Lotti, T; Ortonne, JP; Prignano, F | 1 |
| Carrera, M; Picardo, M | 1 |
| Ban, I; Harii, K; Kobayashi, Y; Kurita, M; Miyamoto, S; Momosawa, A; Ozaki, M | 1 |
| Bruce, S | 2 |
| Agarwal, R; Garg, VK; Sarkar, R | 1 |
| Kato, H; Kurita, M; Yoshimura, K | 1 |
| Chan, R; Chang, SE; Kerrouche, N; Lee, ES; Lee, MH; Legarda-Montinola, F; Leow, YH; Park, KC; Shek, S; Tay, YK; Thomas, G; Tsai, RY; Tsai, TH; Verallo-Rowell, V | 1 |
| Adigun, CG; Pandya, AG | 1 |
| Benitez, AL; Bussear, EW; Cardona, LM; Colón, LE; Johnson, LA; Rendon, M | 1 |
| Garg, T; Gupta, TP; Srihar, R | 1 |
| Arellano, I; Cestari, T; Hexsel, D; Ortonne, JP | 1 |
| Biron, J; Gold, MH; Goldman, MP; Woodhall, KE | 1 |
| Bergstrom, KG; Que, SK | 1 |
| Bhawan, J; Byers, HR; Colón, LE; Gottschalk, R; Grimes, P; Guevara, IL; Johnson, LA; Keady, M; Pandya, AG | 1 |
| Alikhan, A; Balkrishnan, R; Daly, M; Feldman, SR; Wu, J | 1 |
| Leyden, JJ; Parr, L | 1 |
| Jeong, SY; Kim, IH; Kim, WS; Shin, JB; Yeo, UC | 1 |
| Bhawan, J; Colón, LE; Gottschalk, RW; Grimes, PE; Guevara, IL; Johnson, LA; Pandya, AG | 1 |
| Beek, JF; Bos, JD; Kroon, MW; Nieuweboer-Krobotová, L; van der Veen, JP; Wind, BS; Wolkerstorfer, A | 1 |
| Pratchyapruit, W; Sindhavananda, J; Tagami, H; Vashrangsi, N | 1 |
| Colón, LE; Gold, MH; Goldman, MP; Gottschalk, RW; Johnson, LA; Palm, MD; Preston, N | 1 |
| Godse, KV; Sakhia, J | 1 |
| Arellano, I; Azulay-Abulafia, L; Bezerra Trindade Neto, P; Cestari, T; Hexsel, D; Machado-Pinto, J; Marques-Hassun, K; Muñoz, H; Ocampo-Candiani, J; Paliargues, F; Rego, V; Rivitti-Machado, MC; Sittart, JA; Trindade de Almeida, AR | 1 |
| Kenkel, J; Schlessinger, J; Werschler, P | 1 |
| Bahadoran, P; Fontas, E; Kang, HY; Lacour, JP; Ortonne, JP; Passeron, T | 1 |
| Bolanca, Z; Kolić, M; Ljubicić, I; Misanović, B; Situm, M | 1 |
| Kauvar, AN | 1 |
| Bencini, PL; Galimberti, MG; Pellacani, G; Tourlaki, A | 1 |
| Garruto, J; Gotz, V; Herndon, JH; Makino, ET; Mehta, RC; Sigler, ML | 1 |
| Grimes, P; Watson, J | 1 |
| Dreher, F; Monheit, GD | 1 |
| Harii, K; Iida, S; Kurita, M; Ohura, N; Sato, S; Takushima, A | 1 |
| Lee, AY; Noh, M | 1 |
| Chaudhary, S; Dayal, S | 1 |
| Rizer, RL; Thornfeldt, C; Trookman, NS | 1 |
| Chen, N; Dahl, A; Draelos, Z; Krol, Y; Oresajo, C; Yatskayer, M | 1 |
| Courselle, P; De Beer, JO; De Paepe, K; Deconinck, E; Desmedt, B; Rogiers, V; Van Hoeck, E | 1 |
| Cheong, KA; Kim, CH; Lee, AY; Noh, M | 1 |
| Hexsel, C; Hexsel, D; Porto, MD; Siega, C | 1 |
| Fernandes, JD; Hexsel, D; Siega, C; Soirefmann, M | 1 |
| Cheong, KA; Kim, CH; Kim, HJ; Kim, JY; Lee, AY; Lim, WS; Noh, M | 1 |
| Ngawhirunpat, T; Opanasopit, P; Rojanarata, T; Tidjarat, S; Winotapun, W | 1 |
| Bahadoran, P; Boukari, F; Fontas, E; Hammami Ghorbel, H; Lacour, JP; Montaudié, H; Passeron, T | 1 |
| Chen, N; Draelos, ZD; Krol, Y; Oresajo, C; Raab, S; Yatskayer, M | 1 |
| Dang, Y; Gong, Z; Lai, W; Li, L; Liu, L; Wang, X; Yang, Q; Zhao, G; Zheng, M; Zou, Y | 1 |
| Arenas, E; Castillo-Martínez, C; González, FJ; León-Bejarano, F; Moncada, B; Ramírez-Elías, MG | 1 |
| Abbas, SS; Bebawy, LI; Elghobashy, MR; Shokry, RF | 1 |
| Eshghi, G; Esna Ashari, F; Khezrian, L | 1 |
| Bansal, S; Garg, V; Gupta, C; Sarkar, R; Sethi, S | 1 |
| Shokeen, D | 1 |
| Dryer, L; Rendon, M | 1 |
| Barysch, MJ; Dreier, J; Dummer, R; Imhof, L; Kolm, I | 1 |
| Kapoor, S; Parmar, NV; Sarkar, R | 1 |
| Fang, JY; Hsieh, PW; Huang, CW; Hung, CF; Lin, CH | 1 |
| Cheong, KA; Lee, AY; Lee, TR | 1 |
| Cabrera-Alonso, R; González, FJ; Guevara, E; Moncada, B; Ramírez-Elías, MG | 1 |
| El-Deen, AK; Ibrahim, F; Sharaf El-Din, MK; Shimizu, K | 1 |
| Chang, CC; Chang, TM; Chen, YT; Chiang, HM; Chiu, PC; Huang, YH; Lin, BS; Lin, ET; Lin, HY; Wang, KY; Wang, YJ | 1 |
| Andanooru Chandrappa, NK; Banavase Channakeshavaiah, R | 1 |
| de Abreu, L; de Barros, MH; Ramírez-Oliveros, JF; Tamler, C; Vilhena, P | 1 |
| Jawade, S; Kulkarni, S; Madke, B; Sahu, PJ; Saoji, V; Singh, AL | 1 |
13 review(s) available for hydroquinone and tretinoin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Melasma. Etiologic and therapeutic considerations.
Topics: Administration, Cutaneous; Chemexfoliation; Dermatologic Agents; Dicarboxylic Acids; Female; Humans; Hydroquinones; Keratolytic Agents; Laser Therapy; Male; Melanosis; Pregnancy; Tretinoin; United States; United States Food and Drug Administration | 1995 |
Exogenous ochronosis. An update on clinical features, causative agents and treatment options.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Bacterial Agents; Caustics; Cosmetics; Cryotherapy; Dermabrasion; Dermatologic Agents; Female; Humans; Hydroquinones; Incidence; Keratolytic Agents; Laser Therapy; Middle Aged; Ochronosis; Resorcinols; Skin Care; South Africa; Sunscreening Agents; Tetracycline; Time Factors; Tretinoin; Trichloroacetic Acid | 2001 |
Management of dyschromias in ethnic skin.
Topics: Administration, Cutaneous; Arbutin; Black People; Dicarboxylic Acids; Humans; Hydroquinones; Keratolytic Agents; Pigmentation Disorders; Pyrones; Tretinoin | 2004 |
Hyperpigmentation: an overview of the common afflictions.
Topics: Chemexfoliation; Cryotherapy; Dermatologic Agents; Dicarboxylic Acids; Humans; Hydroquinones; Hyperpigmentation; Inflammation; Keratolytic Agents; Laser Therapy; Lentigo; Melanosis; Patient Education as Topic; Primary Prevention; Risk Factors; Self Care; Sunlight; Tretinoin | 2004 |
A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream.
Topics: Administration, Cutaneous; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Melanosis; Time Factors; Tretinoin | 2006 |
The treatment of melasma: a review of clinical trials.
Topics: Adrenal Cortex Hormones; Adult; Chemexfoliation; Clinical Trials as Topic; Combined Modality Therapy; Dermabrasion; Dicarboxylic Acids; Double-Blind Method; Drug Therapy, Combination; Female; Flavonoids; Gonadal Steroid Hormones; Humans; Hydroquinones; Laser Coagulation; Melanosis; Phototherapy; Plant Extracts; Pregnancy; Pregnancy Complications; Pyrones; Randomized Controlled Trials as Topic; Skin; Sunlight; Treatment Outcome; Tretinoin; Ultraviolet Rays | 2006 |
New and experimental treatments of cloasma and other hypermelanoses.
Topics: Chemexfoliation; Dermatologic Agents; Drug Combinations; Flavonoids; Glucocorticoids; Humans; Hydroquinones; Hydroxybenzoates; Hyperpigmentation; Laser Therapy; Lasers; Melanosis; Retinoids; Tretinoin | 2007 |
Cosmeceuticals for the attenuation of extrinsic and intrinsic dermal aging.
Topics: Administration, Topical; Antioxidants; Benzoquinones; Cosmetics; Dermatologic Agents; Drug Combinations; Humans; Hydroquinones; Retinoids; Skin Aging; Tretinoin; Ubiquinone | 2008 |
Melasma in Latin America: options for therapy and treatment algorithm.
Topics: Algorithms; Drug Therapy, Combination; Evidence-Based Medicine; Fluocinolone Acetonide; Humans; Hydroquinones; Latin America; Melanosis; Quality of Life; Tretinoin | 2009 |
Melasma--updated treatments.
Topics: Adrenal Cortex Hormones; Female; Humans; Hydroquinones; Keratolytic Agents; Male; Melanosis; Photochemotherapy; Radiation-Protective Agents; Tretinoin | 2011 |
The regulation of epidermal melanogenesis via cAMP and/or PKC signaling pathways: insights for the development of hypopigmenting agents.
Topics: Animals; Antioxidants; Cyclic AMP; Epidermal Cells; Epidermis; Humans; Hydroquinones; Melanins; Melanocytes; Protein Kinase C; Radiation-Protective Agents; Signal Transduction; Tretinoin; Ultraviolet Rays | 2013 |
Postinflammatory hyperpigmentation in patients with skin of color.
Topics: Chemexfoliation; Dermatitis; Dermatologic Agents; Dicarboxylic Acids; Drug Combinations; Ethanol; Glycolates; Humans; Hydroquinones; Hyperpigmentation; Inflammation; Keratolytic Agents; Lactic Acid; Pyrones; Resorcinols; Salicylates; Salicylic Acid; Skin Pigmentation; Tretinoin | 2016 |
46 trial(s) available for hydroquinone and tretinoin
| Article | Year |
|---|---|
Usefulness of retinoic acid in the treatment of melasma.
Topics: Administration, Topical; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydroquinones; Melanosis; Sunlight; Sunscreening Agents; Tretinoin | 1986 |
Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study.
Topics: Administration, Topical; Adult; Black People; Chemexfoliation; Dermatitis; Drug Combinations; Female; Glycolates; Humans; Hydroquinones; Hyperpigmentation; Keratolytic Agents; Middle Aged; Pilot Projects; Tretinoin | 1997 |
Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic acid, hydroquinone and hydrocortisone): clinical and histological studies.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Asian People; Dermis; Drug Administration Schedule; Drug Therapy, Combination; Epidermis; Female; Follow-Up Studies; Humans; Hydrocortisone; Hydroquinones; Keratolytic Agents; Melanosis; Middle Aged; Radiation-Protective Agents; Treatment Outcome; Tretinoin | 1998 |
Effect of pretreatment on the incidence of hyperpigmentation following cutaneous CO2 laser resurfacing.
Topics: Administration, Cutaneous; Adult; Carbon Dioxide; Dermatologic Surgical Procedures; Facial Dermatoses; Female; Glycolates; Humans; Hydroquinones; Hyperpigmentation; Keratolytic Agents; Laser Therapy; Male; Middle Aged; Premedication; Radiation-Protective Agents; Tretinoin | 1999 |
Melasma.
Topics: Adult; Demography; Female; Humans; Hydroquinones; Keratolytic Agents; Melanosis; Middle Aged; Radiation-Protective Agents; Sunlight; Treatment Outcome; Tretinoin | 1999 |
The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study.
Topics: Administration, Topical; Adult; Chemexfoliation; Drug Combinations; Female; Glycolates; Humans; Hydroquinones; Keratolytic Agents; Male; Melanosis; Middle Aged; Severity of Illness Index; Treatment Outcome; Tretinoin | 2002 |
Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma.
Topics: Administration, Topical; Adolescent; Adult; Chemexfoliation; Double-Blind Method; Female; Humans; Hydroquinones; Hyperpigmentation; Keratolytic Agents; Male; Melanosis; Tretinoin | 2004 |
Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Anisoles; Double-Blind Method; Drug Therapy, Combination; Face; Female; Forearm; Humans; Hydroquinones; Keratolytic Agents; Lentigo; Male; Middle Aged; Treatment Outcome; Tretinoin | 2004 |
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.
Topics: Antioxidants; Drug Combinations; Facial Dermatoses; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Male; Melanosis; Middle Aged; Ointments; Treatment Outcome; Tretinoin | 2005 |
Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream.
Topics: Administration, Topical; Adult; Dermatologic Agents; Double-Blind Method; Drug Combinations; Emollients; Female; Humans; Hydroquinones; Hyperpigmentation; Middle Aged; Skin Aging; Treatment Outcome; Tretinoin; Vitamin A | 2005 |
Community-based trial of a triple-combination agent for the treatment of facial melasma.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Dermatologic Agents; Drug Combinations; Facial Dermatoses; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Ointments; Prospective Studies; Treatment Outcome; Tretinoin; United States | 2006 |
A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma.
Topics: Administration, Topical; Adult; Drug Combinations; Emollients; Facial Dermatoses; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Tretinoin | 2007 |
Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma.
Topics: Administration, Topical; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Treatment Outcome; Tretinoin | 2007 |
Comparative evaluation of beneficiary effects of priming agents (2% hydroquinone and 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels.
Topics: Adolescent; Adult; Chemexfoliation; Female; Glycolates; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Treatment Outcome; Tretinoin | 2008 |
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Asian People; Double-Blind Method; Drug Combinations; Facial Dermatoses; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Ointments; Patient Satisfaction; Treatment Outcome; Tretinoin | 2008 |
Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
Topics: Administration, Cutaneous; Adult; Chemexfoliation; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Follow-Up Studies; Glycolates; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Ointments; Pilot Projects; Severity of Illness Index; Treatment Outcome; Tretinoin | 2008 |
Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study.
Topics: Administration, Cutaneous; Adult; Female; Follow-Up Studies; Humans; Hydroquinones; Hyperpigmentation; Keratolytic Agents; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Rejuvenation; Single-Blind Method; Skin Aging; Tretinoin | 2009 |
A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream.
Topics: Administration, Cutaneous; Adult; Atrophy; Dermatologic Agents; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Skin; Tretinoin | 2009 |
Treating photodamage of the décolletage area with a novel copper zinc malonate complex plus hydroquinone and tretinoin.
Topics: Adult; Copper; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Hydroquinones; Malonates; Middle Aged; Neck; Patient Satisfaction; Skin Aging; Tretinoin; Zinc | 2010 |
Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
Topics: Administration, Topical; Adult; Antioxidants; Combined Modality Therapy; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Lasers, Solid-State; Male; Melanosis; Middle Aged; Treatment Outcome; Tretinoin | 2010 |
Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study.
Topics: Administration, Topical; Adult; Female; Humans; Hydroquinones; Laser Therapy; Melanosis; Middle Aged; Pilot Projects; Recurrence; Treatment Outcome; Tretinoin; Triamcinolone Acetonide | 2011 |
Instrumental analysis of the pattern of improvement and that of recurrence of melasma in Thai females treated with Kligman-Willis triple combination therapy: confirmation by using its two different formulae.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Asian People; Chemistry, Pharmaceutical; Drug Combinations; Female; Humans; Hydroquinones; Keratolytic Agents; Melanosis; Radiation-Protective Agents; Recurrence; Sunscreening Agents; Thailand; Treatment Outcome; Tretinoin | 2011 |
Sequential treatment with triple combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive (control) cream and intense pulsed light in patients with moderate to severe melasma.
Topics: Adult; Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Keratolytic Agents; Low-Level Light Therapy; Male; Melanosis; Middle Aged; Radiation-Protective Agents; Tretinoin | 2011 |
Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity.
Topics: Dermatologic Agents; Drug Therapy, Combination; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Quality of Life; Recurrence; Severity of Illness Index; Surveys and Questionnaires; Tretinoin | 2012 |
Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type A.
Topics: Administration, Cutaneous; Botulinum Toxins, Type A; Face; Female; Follow-Up Studies; Humans; Hydroquinones; Hyperpigmentation; Keratolytic Agents; Male; Middle Aged; Patient Satisfaction; Rejuvenation; Skin Aging; Skin Care; Surveys and Questionnaires; Time Factors; Tretinoin | 2011 |
Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study.
Topics: Adult; Bleaching Agents; Dermatologic Agents; Drug Combinations; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Lasers, Dye; Melanosis; Middle Aged; Patient Satisfaction; Single-Blind Method; Tretinoin | 2011 |
Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
Topics: Adult; Antioxidants; Ascorbic Acid; Combined Modality Therapy; Dermabrasion; Female; Follow-Up Studies; Humans; Hydroquinones; Keratolytic Agents; Lasers; Lasers, Solid-State; Melanosis; Middle Aged; Single-Blind Method; Sunscreening Agents; Treatment Outcome; Tretinoin | 2012 |
Combination of fractional erbium-glass laser and topical therapy in melasma resistant to triple-combination cream.
Topics: Adult; Combined Modality Therapy; Dermatologic Agents; Female; Humans; Hydrocortisone; Hydroquinones; Lasers, Solid-State; Low-Level Light Therapy; Melanosis; Middle Aged; Treatment Failure; Treatment Outcome; Tretinoin; Young Adult | 2014 |
Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Topics: Adult; Aged; Antioxidants; Chemistry, Pharmaceutical; Color; Dermatologic Agents; Dinoprostone; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydroquinones; Hyperpigmentation; Middle Aged; Prostaglandin Antagonists; Surveys and Questionnaires; Treatment Outcome; Tretinoin | 2012 |
Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Topics: Administration, Cutaneous; Antioxidants; Drug Therapy, Combination; Female; Humans; Hydroquinones; Keratolytic Agents; Melanosis; Middle Aged; Patient Satisfaction; Severity of Illness Index; Skin Care; Skin Pigmentation; Sunscreening Agents; Time Factors; Treatment Outcome; Tretinoin | 2013 |
Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Dermatologic Agents; Drug Combinations; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Melanosis; Middle Aged; Severity of Illness Index; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome; Tretinoin; Young Adult | 2013 |
Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma.
Topics: Adult; Anti-Inflammatory Agents; Antioxidants; Chemexfoliation; Female; Glycolates; Humans; Hydrocortisone; Hydroquinones; Hyperpigmentation; Hypertrichosis; Irritants; Keratolytic Agents; Male; Melanosis; Treatment Outcome; Tretinoin; Young Adult | 2013 |
Dyspigmentation, skin physiology, and a novel approach to skin lightening.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Drug Combinations; Ellagic Acid; Face; Female; Humans; Hydroquinones; Male; Middle Aged; Patient Satisfaction; Pigmentation Disorders; Salicylic Acid; Skin Lightening Preparations; Treatment Outcome; Tretinoin; Yeasts | 2013 |
Triple combination as adjuvant to cryotherapy in the treatment of solar lentigines: investigator-blinded, randomized clinical trial.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Chemotherapy, Adjuvant; Cryotherapy; Drug Combinations; Erythema; Female; Fluocinolone Acetonide; Hand Dermatoses; Humans; Hydroquinones; Lentigo; Male; Melanins; Middle Aged; Prospective Studies; Single-Blind Method; Skin Cream; Sunlight; Tretinoin | 2015 |
Objective assessment of erythema and pigmentation of melasma lesions and surrounding areas in long-term management regimens with triple combination.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antioxidants; Drug Therapy, Combination; Erythema; Fluocinolone Acetonide; Humans; Hydroquinones; Keratolytic Agents; Long-Term Care; Maintenance Chemotherapy; Melanins; Melanosis; Prospective Studies; Single-Blind Method; Skin; Skin Pigmentation; Tretinoin; Young Adult | 2014 |
Copper Bromide Laser vs Triple-Combination Cream for the Treatment of Melasma: A Randomized Clinical Trial.
Topics: Adult; Bromides; Copper; Dexamethasone; Drug Combinations; Female; Humans; Hydroquinones; Laser Therapy; Male; Melanosis; Middle Aged; Prospective Studies; Severity of Illness Index; Single-Blind Method; Skin Cream; Treatment Outcome; Tretinoin | 2015 |
A method for maintaining the clinical results of 4% hydroquinone and 0.025% tretinoin with a cosmeceutical formulation.
Topics: Adult; Cosmeceuticals; Double-Blind Method; Female; Humans; Hydroquinones; Hyperpigmentation; Keratolytic Agents; Male; Middle Aged; Pigmentation Disorders; Skin; Treatment Outcome; Tretinoin | 2015 |
Efficacy and safety of fluocinolone acetonide, hydroquinone, and tretinoin cream in chinese patients with melasma: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study.
Topics: Adolescent; Adult; Asian People; Double-Blind Method; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Tretinoin; Young Adult | 2015 |
Raman spectroscopy analysis of the skin of patients with melasma before standard treatment with topical corticosteroids, retinoic acid, and hydroquinone mixture.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Dermatologic Agents; Drug Combinations; Female; Humans; Hydroquinones; Keratolytic Agents; Male; Melanins; Melanosis; Middle Aged; Skin; Spectrum Analysis, Raman; Treatment Outcome; Tretinoin; Young Adult | 2016 |
Comparison between Intralesional Triamcinolone and Kligman's Formula in Treatment of Melasma.
Topics: Administration, Topical; Adult; Dexamethasone; Female; Humans; Hydroquinones; Melanosis; Middle Aged; Skin Pigmentation; Treatment Outcome; Tretinoin; Triamcinolone | 2016 |
Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma.
Topics: Adult; Antioxidants; Chemexfoliation; Drug Combinations; Female; Follow-Up Studies; Glycolates; Humans; Hydroquinones; India; Keratolytic Agents; Male; Mandelic Acids; Melanosis; Middle Aged; Phytic Acid; Prospective Studies; Salicylic Acid; Severity of Illness Index; Treatment Outcome; Tretinoin; Young Adult | 2016 |
A Prospective Trial Comparing Q-Switched Ruby Laser and a Triple Combination Skin-Lightening Cream in the Treatment of Solar Lentigines.
Topics: Aged; Dexamethasone; Drug Combinations; Erythema; Female; Hand Dermatoses; Humans; Hydroquinones; Lasers, Solid-State; Lentigo; Male; Middle Aged; Pain; Prospective Studies; Skin Cream; Skin Lightening Preparations; Tretinoin | 2016 |
Treatment of Postinflammatory Hyperpigmentation With a Combination of Glycolic Acid Peels and a Topical Regimen in Dark-Skinned Patients: A Comparative Study.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Chemexfoliation; Drug Combinations; Facial Dermatoses; Female; Glycolates; Humans; Hydrocortisone; Hydroquinones; Hyperpigmentation; India; Inflammation; Keratolytic Agents; Male; Severity of Illness Index; Tretinoin; Young Adult | 2017 |
Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma.
Topics: Adult; Asian People; Combined Modality Therapy; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Lasers, Solid-State; Melanosis; Middle Aged; Ointments; Prospective Studies; Single-Blind Method; Treatment Outcome; Tretinoin | 2020 |
Topical metformin in the treatment of melasma: A preliminary clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Metformin; Middle Aged; Ointments; Patient Satisfaction; Prospective Studies; Severity of Illness Index; Skin Lightening Preparations; Skin Pigmentation; Treatment Outcome; Tretinoin; Young Adult | 2020 |
Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Drug Combinations; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Prospective Studies; Severity of Illness Index; Sunscreening Agents; Tranexamic Acid; Treatment Outcome; Tretinoin; Young Adult | 2020 |
48 other study(ies) available for hydroquinone and tretinoin
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Induced differentiation of HL-60 promyelocytic leukemia cells to monocyte/macrophages is inhibited by hydroquinone, a hematotoxic metabolite of benzene.
Topics: Benzene Derivatives; Benzoquinones; Calcitriol; Cell Differentiation; Dose-Response Relationship, Drug; Granulocytes; Humans; Hydroquinones; In Vitro Techniques; Interleukin-1; Leukemia, Promyelocytic, Acute; Macrophages; Monocytes; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured | 1992 |
UVB-induced pigmentation in hairless mice as an in vivo assay for topical skin-depigmenting activity.
Topics: Animals; Anisoles; Female; Hydroquinones; Mice; Mice, Hairless; Pyrones; Skin; Skin Pigmentation; Tretinoin; Ultraviolet Rays | 1989 |
Effects of benzene metabolite treatment on granulocytic differentiation and DNA adduct formation in HL-60 cells.
Topics: Benzene Derivatives; Cell Death; Cell Differentiation; Cell Division; DNA; DNA Adducts; Granulocytes; HL-60 Cells; Humans; Hydroquinones; Leukemia, Myeloid; Mutagens; Phosphorus Radioisotopes; Tretinoin | 1996 |
Ultrapulse carbon dioxide laser with CPG scanner for full-face resurfacing for rhytids, photoaging, and acne scars.
Topics: Acne Vulgaris; Acyclovir; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antiviral Agents; Carbon Dioxide; Cicatrix; Dexamethasone; Epithelium; Erythema; Facial Dermatoses; Female; Follow-Up Studies; Glycolates; Herpesviridae Infections; Humans; Hydroquinones; Keratolytic Agents; Laser Therapy; Middle Aged; Radiation-Protective Agents; Rhytidoplasty; Skin Aging; Skin Care; Therapy, Computer-Assisted; Tretinoin; Wound Healing | 1997 |
Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester, IL-1 and retinoic acid, but not by reactive oxygen species.
Topics: Amyloid beta-Protein Precursor; Animals; Antineoplastic Agents; Benzoflavones; Carcinogens; Cation Exchange Resins; Cell Survival; Cells, Cultured; Curcumin; DNA; Gene Expression Regulation; Hippocampus; Hydrogen Peroxide; Hydroquinones; Indicators and Reagents; Interleukin-1; Lipids; Mutagens; Neurons; NF-kappa B; Phorbol Esters; Promoter Regions, Genetic; Rats; Reactive Oxygen Species; Transfection; Tretinoin; Tumor Necrosis Factor-alpha | 1998 |
Solar-induced postinflammatory hyperpigmentation after laser hair removal.
Topics: Administration, Topical; Adult; Drug Therapy, Combination; Hair Removal; Humans; Hydroquinones; Hyperpigmentation; Hypertrichosis; Laser Therapy; Sunlight; Sunscreening Agents; Tretinoin; Triamcinolone; Trichloroacetic Acid | 1999 |
Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals.
Topics: Administration, Topical; Adolescent; Adult; Asian People; Female; Gels; Humans; Hydroquinones; Hyperpigmentation; Keratolytic Agents; Male; Middle Aged; Ointments; Tretinoin | 2000 |
Nothing like a little science now and then.
Topics: Erythema; Glycolates; Humans; Hydroquinones; Keratolytic Agents; Laser Therapy; Lasers; Pigmentation Disorders; Radiation-Protective Agents; Randomized Controlled Trials as Topic; Time Factors; Tretinoin | 1999 |
Nail staining from hydroquinone cream.
Topics: Administration, Topical; Adult; Coloring Agents; Facial Dermatoses; Follow-Up Studies; Humans; Hydroquinones; Hyperpigmentation; Male; Nail Diseases; Tretinoin | 2000 |
Melasma treated with hydroquinone, tretinoin, and a fluorinated steroid.
Topics: Adult; Anti-Inflammatory Agents; Antioxidants; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydroquinones; Keratolytic Agents; Melanosis; Middle Aged; Retrospective Studies; Skin; Treatment Outcome; Tretinoin; Triamcinolone | 2001 |
Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes.
Topics: Animals; Cell Line; Cells, Cultured; Drug Synergism; Humans; Hydrocortisone; Hydroquinones; Keratolytic Agents; Melanins; Melanocytes; Mice; Monophenol Monooxygenase; Skin; Skin Pigmentation; Tretinoin | 2001 |
Cosmetic color improvement of the nipple-areola complex by optimal use of tretinoin and hydroquinone.
Topics: Administration, Cutaneous; Adolescent; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gels; Humans; Hydroquinones; Hyperpigmentation; Keratolytic Agents; Nipples; Treatment Outcome; Tretinoin | 2002 |
Enhancement of the depigmenting effect of hydroquinone and 4-hydroxyanisole by all-trans-retinoic acid (tretinoin): the impairment of glutathione-dependent cytoprotection?
Topics: Animals; Anisoles; Drug Therapy, Combination; Enzyme Inhibitors; Glutathione; Glutathione Transferase; Guinea Pigs; Humans; Hydroquinones; Keratolytic Agents; Melanocytes; Skin Pigmentation; Swine; Tretinoin | 2003 |
Lustra, Lustra-AF and Alustra.
Topics: Drug Therapy, Combination; Humans; Hydroquinones; Hyperpigmentation; Melanosis; Tretinoin | 2003 |
Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for acquired dermal melanocytosis.
Topics: Adolescent; Adult; Combined Modality Therapy; Dermatologic Agents; Female; Humans; Hydroquinones; Hyperpigmentation; Laser Therapy; Middle Aged; Nevus, Pigmented; Treatment Outcome; Tretinoin | 2003 |
4% hydroquinone versus 4% hydroquinone, 0.05% dexamethasone and 0.05% tretinoin in the treatment of melasma: a comparative study.
Topics: Administration, Topical; Dermatologic Agents; Dexamethasone; Drug Combinations; Humans; Hydroquinones; Melanosis; Treatment Outcome; Tretinoin | 2005 |
Repeated treatment protocols for melasma and acquired dermal melanocytosis.
Topics: Adult; Antioxidants; Asian People; Combined Modality Therapy; Drug Therapy, Combination; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hydroquinones; Keratolytic Agents; Low-Level Light Therapy; Male; Melanosis; Middle Aged; Nevus, Pigmented; Retreatment; Skin Neoplasms; Treatment Outcome; Tretinoin | 2006 |
Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation.
Topics: Administration, Topical; Drug Therapy, Combination; Facial Dermatoses; Fluocinolone Acetonide; Glucocorticoids; Hispanic or Latino; Humans; Hydroquinones; Hyperpigmentation; Keratolytic Agents; Latin America; Salicylic Acid; Skin Pigmentation; Tretinoin | 2006 |
Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
Topics: Adult; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Language; Male; Melanosis; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Tretinoin | 2006 |
Therapeutical approaches in melasma.
Topics: Chemexfoliation; Cosmetics; Dermatologic Agents; Dicarboxylic Acids; Drug Combinations; Humans; Hydroquinones; Hydroxybenzoates; Laser Therapy; Melanosis; Pyrones; Tretinoin | 2007 |
Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for periorbital skin hyperpigmentation in Asians.
Topics: Administration, Topical; Adult; Asian People; Dermatologic Agents; Eyelids; Female; Humans; Hydroquinones; Hyperpigmentation; Laser Therapy; Lasers; Male; Middle Aged; Ointments; Skin Pigmentation; Tretinoin | 2008 |
An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
Topics: Administration, Topical; Adult; Antioxidants; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Middle Aged; Treatment Outcome; Tretinoin; Vitamin A | 2007 |
Complementary effects of topical antiaging treatments in conjunction with aesthetic procedures.
Topics: Administration, Topical; Antioxidants; Botulinum Toxins, Type A; Cosmetic Techniques; Drug Combinations; Esthetics; Face; Humans; Hydroquinones; Keratolytic Agents; Laser Therapy; Rejuvenation; Skin; Skin Aging; Tretinoin | 2008 |
A therapeutic strategy based on histological assessment of hyperpigmented skin lesions in Asians.
Topics: Administration, Topical; Adolescent; Adult; Asian People; Biopsy; Combined Modality Therapy; Dermatologic Agents; Female; Humans; Hydroquinones; Hyperpigmentation; Laser Therapy; Male; Melanins; Middle Aged; Skin; Tretinoin; Young Adult | 2009 |
Improvement of idiopathic acanthosis nigricans with a triple combination depigmenting cream.
Topics: Acanthosis Nigricans; Administration, Topical; Adult; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Treatment Outcome; Tretinoin | 2009 |
Acquired dermal melanocytosis involving the hand.
Topics: Administration, Cutaneous; Adolescent; Drug Combinations; Hand; Humans; Hydroquinones; Lasers, Solid-State; Male; Melanocytes; Mometasone Furoate; Pigmentation Disorders; Pregnadienediols; Skin; Treatment Outcome; Tretinoin | 2009 |
Hyperpigmentation: old problem, new therapies.
Topics: Chemexfoliation; Dermatologic Agents; Dicarboxylic Acids; Fluocinolone Acetonide; Humans; Hydroquinones; Hyperpigmentation; Laser Therapy; Tretinoin | 2009 |
Cost-effectiveness of a hydroquinone/tretinoin/fluocinolone acetonide cream combination in treating melasma in the United States.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Drug Costs; Drug Therapy, Combination; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Ointments; Treatment Outcome; Tretinoin; United States | 2010 |
Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.
Topics: Administration, Topical; Adolescent; Adult; Aged; Drug Administration Schedule; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Ointments; Skin Pigmentation; Tretinoin; Young Adult | 2010 |
Triple combination and glycolic acid peels in melasma in Indian patients.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Antioxidants; Chemexfoliation; Drug Combinations; Face; Female; Fluocinolone Acetonide; Glycolates; Humans; Hydroquinones; India; Keratolytic Agents; Male; Melanosis; Middle Aged; Treatment Outcome; Tretinoin; Young Adult | 2011 |
Adverse effect profile of common components of skin-lightening cosmetics.
Topics: Adrenal Cortex Hormones; Cosmetics; Humans; Hydroquinones; Mercury; Skin; Skin Pigmentation; Tretinoin | 2011 |
Skin-lightening creams: warn women of child-bearing age about the risks.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Cosmetics; Female; Humans; Hydroquinones; Mercury; Pregnancy; Risk; Skin Pigmentation; Tretinoin; Wound Healing | 2011 |
Silicone sheet containing all-trans retinoic acid and hydroquinone for the treatment of epidermal melanosis.
Topics: Adult; Aged; Antioxidants; Drug Therapy, Combination; Female; Humans; Hydroquinones; Keratolytic Agents; Lentigo; Male; Melanosis; Middle Aged; Silicones; Skin; Skin Lightening Preparations; Tretinoin | 2013 |
Blockade of melanin synthesis, activation and distribution pathway by a nonprescription natural regimen is equally effective to a multiple prescription-based therapeutic regimen.
Topics: Adult; Biological Products; Dermatologic Agents; Female; Follow-Up Studies; Humans; Hydroquinones; Hyperpigmentation; Melanins; Melanosis; Middle Aged; Nonprescription Drugs; Prospective Studies; Single-Blind Method; Treatment Outcome; Tretinoin | 2013 |
Characterization of suspected illegal skin whitening cosmetics.
Topics: Belgium; Chromatography, High Pressure Liquid; Clobetasol; Cosmetics; Dermatologic Agents; European Union; Glucocorticoids; Humans; Hydroquinones; Legislation, Drug; Mass Spectrometry; Skin Lightening Preparations; Tretinoin | 2014 |
S100B as a potential biomarker for the detection of cytotoxicity of melanocytes.
Topics: Adult; Antigens, CD; Apoptosis; Biomarkers; Catechols; Cell Adhesion Molecules, Neuronal; Cell Survival; Cells, Cultured; Dermatologic Agents; Extracellular Signal-Regulated MAP Kinases; Female; Fetal Proteins; Fibroblasts; Gene Knockdown Techniques; Humans; Hydroquinones; Keratinocytes; L-Lactate Dehydrogenase; Male; Melanocytes; Middle Aged; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Receptor for Advanced Glycation End Products; Receptors, Immunologic; S100 Calcium Binding Protein beta Subunit; Skin; Sodium Dodecyl Sulfate; Tretinoin | 2014 |
Retinoic acid and hydroquinone induce inverse expression patterns on cornified envelope-associated proteins: implication in skin irritation.
Topics: Animals; Cells, Cultured; Chromosomes, Human, Pair 1; Female; Gene Expression Profiling; Humans; Hydroquinones; Irritants; Mice; Mice, Inbred C57BL; Skin; Sodium Dodecyl Sulfate; Tretinoin | 2014 |
Uniaxially aligned electrospun cellulose acetate nanofibers for thin layer chromatographic screening of hydroquinone and retinoic acid adulterated in cosmetics.
Topics: Cellulose; Chromatography, Thin Layer; Cosmetics; Hydroquinones; Nanofibers; Silicon Dioxide; Tretinoin | 2014 |
Successive ratio subtraction coupled with constant multiplication spectrophotometric method for determination of hydroquinone in complex mixture with its degradation products, tretinoin and methyl paraben.
Topics: Antineoplastic Agents; Antioxidants; Benzoquinones; Calibration; Drug Stability; Hydroquinones; Limit of Detection; Parabens; Pharmaceutical Preparations; Preservatives, Pharmaceutical; Spectrophotometry; Tretinoin | 2016 |
Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
Topics: Administration, Cutaneous; Adult; Aged; Drug Compounding; Drug Therapy, Combination; Female; Humans; Hydroquinones; Melanosis; Middle Aged; Single-Blind Method; Skin Aging; Skin Care; Treatment Outcome; Tretinoin | 2016 |
Anti-melasma codrug of retinoic acid assists cutaneous absorption with attenuated skin irritation.
Topics: Administration, Cutaneous; Animals; Drug Combinations; Female; Hydrolysis; Hydroquinones; Interleukin-6; Irritants; Melanosis; Mice; Mice, Nude; Skin Absorption; Solubility; Swine; Tretinoin | 2017 |
Complementary effect of hydroquinone and retinoic acid on corneocyte desquamation with their combination use.
Topics: Adult; Cell Adhesion; Desmocollins; Desmosomes; Drug Synergism; Epidermal Cells; Epidermis; Female; Glycoproteins; Healthy Volunteers; Humans; Hydroquinones; Intercellular Signaling Peptides and Proteins; Keratinocytes; Male; Middle Aged; Primary Cell Culture; Proteolysis; Real-Time Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Serine Peptidase Inhibitor Kazal-Type 5; Skin Absorption; Skin Lightening Preparations; Skin Physiological Phenomena; Tretinoin; Up-Regulation | 2017 |
Detection of hydroquinone by Raman spectroscopy in patients with melasma before and after treatment.
Topics: Adult; Drug Monitoring; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Precision Medicine; Skin; Skin Lightening Preparations; Spectrum Analysis, Raman; Treatment Outcome; Tretinoin; Young Adult | 2019 |
A New HPLC-DAD Method for the Concurrent Determination of Hydroquinone, Hydrocortisone Acetate and Tretinoin in Different Pharmaceuticals for Melasma Treatment.
Topics: Chromatography, High Pressure Liquid; Dermatologic Agents; Drug Combinations; Humans; Hydrocortisone; Hydroquinones; Limit of Detection; Linear Models; Mefenamic Acid; Melanosis; Reproducibility of Results; Tretinoin | 2019 |
Microneedling with Drug Delivery (Hydroquinone 4% Serum) as an Adjuvant Therapy for Recalcitrant Melasma.
Topics: Adult; Combined Modality Therapy; Cosmetic Techniques; Dermatologic Agents; Drug Delivery Systems; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Melanosis; Needles; Quality of Life; Sunscreening Agents; Treatment Outcome; Tretinoin | 2020 |